Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,066 | -63,058 | -45,649 | -33,727 | -20,761 |
| Depreciation Amortization | 56 | 114 | 80 | 55 | 27 |
| Accounts receivable | -1,605 | N/A | N/A | N/A | N/A |
| Other Working Capital | 4,541 | 2,684 | 2,621 | 2,690 | 4,577 |
| Other Operating Activity | 7,021 | 11,219 | 6,682 | 4,464 | 2,205 |
| Operating Cash Flow | $-16,053 | $-49,041 | $-36,266 | $-26,518 | $-13,952 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -79,985 | 11,548 | 8,562 | 43,544 | 33,589 |
| PPE Investments | -45 | -302 | -19 | -17 | -6 |
| Investing Cash Flow | $-80,030 | $11,246 | $8,543 | $43,527 | $33,583 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,365 | 85,527 | 49,094 | 176 | 140 |
| Other Financing Activity | 74,989 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $94,354 | $85,527 | $49,094 | $176 | $140 |
| Beginning Cash Position | 73,046 | 25,314 | 25,314 | 25,314 | 25,314 |
| End Cash Position | 71,317 | 73,046 | 46,685 | 42,499 | 45,085 |
| Net Cash Flow | $-1,729 | $47,732 | $21,371 | $17,185 | $19,771 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,053 | -49,041 | -36,266 | -26,518 | -13,952 |
| Capital Expenditure | -45 | -302 | -19 | -17 | -6 |
| Free Cash Flow | -16,098 | -49,343 | -36,285 | -26,535 | -13,958 |